Internal Medicine, Gastroenterology · Mesquite, TX
NPI
1578724803
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2694 N Galloway Ave Ste 501
Mesquite, TX, 75150
Phone (972) 681-2226
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
4,016 services
Medicare patients, 2024
339
Average age 72
Drug cost, 2024
$738K
1,963 prescriptions
Company payments, 2025
$709
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramalinga Kedika was code 99214 (office e&m - established), 138 times for 101 patients. In total Ramalinga Kedika billed 4,016 services in 37 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 138 | 101 | $94.35 | $13K |
| 45385 Colonoscopy - Lesion Removal | Facility | 93 | 92 | $199.68 | $19K |
| 43239 Upper GI Endoscopy | Facility | 79 | 76 | $74.22 | $5,863 |
| 99204 Office E&M - New | Office | 65 | 65 | $113.23 | $7,360 |
| 99213 Office E&M - Established | Office | 52 | 48 | $62.40 | $3,245 |
| 99203 Office E&M - New | Office | 41 | 41 | $70.88 | $2,906 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 31 | 31 | $170.69 | $5,291 |
| 45380 Lower GI Endoscopy - Other | Facility | 21 | 21 | $94.56 | $1,986 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $100.66 | $1,711 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 16 | 16 | $170.54 | $2,729 |
| 43235 Upper GI Endoscopy | Facility | 13 | 13 | $66.81 | $868 |
| 99232 Hospital E&M - Subsequent | Facility | 12 | 11 | $55.45 | $665 |
| 45378 Lower GI Endoscopy - Other | Facility | 12 | 12 | $132.19 | $1,586 |
By year: 2022 $51K for 431 services; 2023 $51K for 450 services; 2024 $123K for 4,016 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramalinga Kedika prescribed most often to Medicare patients was Omeprazole, with 360 prescriptions and refills. In total Ramalinga Kedika wrote 1,963 Medicare prescriptions that cost $738K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 360 | 490 | 164 | $4,661 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 197 | 197 | 192 | $12K |
| Linzess Linaclotide | 172 | 186 | 55 | $101K |
| Pantoprazole Sodium Generic | 159 | 241 | 69 | $1,235 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 128 | 128 | 124 | $1,907 |
| Cholestyramine Light Cholestyramine | 86 | 108 | 52 | $5,230 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 80 | 80 | 77 | $1,195 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 65 | 67 | 62 | $1,331 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 59 | 59 | 59 | $907 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 54 | 54 | 53 | $7,547 |
| Famotidine Generic | 39 | 51 | 22 | $413 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 36 | 36 | 35 | $6,106 |
| Metronidazole Generic | 33 | 33 | 31 | $286 |
| Mesalamine Generic | 31 | 45 | Under 11 | $6,251 |
| Lactulose Generic | 30 | 32 | 20 | $1,027 |
Brand drugs: - claims; generic drugs: 1,444 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramalinga Kedika $709 ($709 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $255.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $255 |
| Janssen Biotech, Inc. JNJ | 8 | $197 |
| Gilead Sciences, Inc. GILD | 2 | $45.89 |
| Madrigal Pharmaceuticals MDGL | 1 | $31.85 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $30.85 |
| Genzyme Corporation SNY | 1 | $27.07 |
| Lilly USA, LLC LLY | 1 | $25.75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $21.44 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $20.25 |
| Pacira Pharmaceuticals Incorporated PCRX | 1 | $19.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.